Series A funding round for Sparrow Pharmaceuticals raising $50M in May 2021
Series A funding round for Sparrow Pharmaceuticals raising $50M in May 2021
| Investor | Firm Type | Partner |
|---|
OrbiMedLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$155M
Top Valuation
-
Sparrow Pharmaceuticals raised $50M in a Series A round.
The round was announced on 05/01/21.
The round was led by OrbiMed.